EQS-Adhoc: Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.): Termination of voting pool agreement.
|
EQS-Ad-hoc: SHOP APOTHEKE EUROPE N.V. / Key word(s): Miscellaneous
Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.): Termination of voting pool agreement.
22-May-2023 / 22:59 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.): Termination of voting pool agreement.
Sevenum, the Netherlands, 22 May 2023. Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.) has been informed today that the pool agreement of 25 individual shareholders, who at the time of its formation controlled more than 26% of the voting rights, has been terminated due to a recent dilution of their shareholding. The dilution resulted from the capital increase in connection with the formation of a joint venture with Galenica. Subsequently, the shareholding of the pool fell below the threshold of 25% of the total voting rights.
Notwithstanding the dissolution of the pool agreement, the 25 individual shareholders around and including the company's founder Michael Köhler have reaffirmed their continued support for Redcare Pharmacy N.V.
Contact:
rikutis consulting
Thomas Schnorrenberg
Mobil: +49 151 46 53 13 17
E-Mail: [email protected]
End of Inside Information
22-May-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
|
| Language: |
English |
| Company: |
SHOP APOTHEKE EUROPE N.V. |
|
Erik de Rodeweg 11-13 |
|
5975 WD Sevenum |
|
Netherlands |
| Phone: |
0800 - 200 800 300 |
| Fax: |
0800 - 90 70 90 20 |
| E-mail: |
[email protected] |
| Internet: |
www.shop-apotheke-europe.com |
| ISIN: |
NL0012044747, DE000A19Y072 |
| WKN: |
A2AR94, A19Y07 |
| Indices: |
SDAX |
| Listed: |
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: |
1638825 |
| |
| End of Announcement |
EQS News Service |
1638825 22-May-2023 CET/CEST
|
Die wichtigsten Finanzdaten auf einen Blick
|
| |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
| Umsatzerlöse1 |
283,99 |
539,71 |
701,01 |
968,06 |
1.060,32 |
1.204,35 |
1.798,76 |
| EBITDA1,2 |
-12,14 |
-15,56 |
-18,58 |
15,20 |
-38,73 |
-29,66 |
39,99 |
| EBITDA-Marge3 |
-4,27 |
-2,88 |
-2,65 |
1,57 |
-3,65 |
-2,46 |
|
| EBIT1,4 |
-19,20 |
-28,73 |
-33,45 |
-0,87 |
-65,70 |
-69,17 |
-17,30 |
| EBIT-Marge5 |
-6,76 |
-5,32 |
-4,77 |
-0,09 |
-6,20 |
-5,74 |
-0,96 |
| Jahresüberschuss1 |
-21,36 |
-33,61 |
-36,27 |
-16,77 |
-74,19 |
-77,65 |
-11,61 |
| Netto-Marge6 |
-7,52 |
-6,23 |
-5,17 |
-1,73 |
-7,00 |
-6,45 |
-0,65 |
| Cashflow1,7 |
-23,24 |
-23,54 |
-30,37 |
17,80 |
11,64 |
-29,11 |
61,46 |
| Ergebnis je Aktie8 |
-2,25 |
-2,79 |
-2,78 |
-1,17 |
-4,15 |
-4,32 |
-0,73 |
| Dividende8 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen. 
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: Forvis Mazars
|
| INVESTOR-INFORMATIONEN |
| ©boersengefluester.de |
| Redcare Pharmacy |
| WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
| A2AR94 |
143,000 |
Halten |
2.908,98 |
| KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
| 79,44 |
0,00 |
0,00 |
-68,49 |
| KBV |
KCV |
KUV |
EV/EBITDA |
| 5,57 |
47,33 |
1,62 |
76,84 |
| Dividende '22 in € |
Dividende '23 in € |
Div.-Rendite '23
in % |
Hauptversammlung |
| 0,00 |
0,00 |
0,00 |
17.04.2024 |
| Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
| 25.04.2024 |
30.07.2024 |
05.11.2024 |
05.03.2024 |
| Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
| 4,19% |
8,04% |
9,16% |
17,02% |
|
|
SHOP APOTHEKE EUROPE N.V. NL0012044747